Cargando…
Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders
BACKGROUND: Autonomic urinary dysfunction affects patients with progressive supranuclear palsy (PSP); however, the severity and prevalence of urinary dysfunctions in these patients compared with those observed in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA) are unknown. O...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757534/ https://www.ncbi.nlm.nih.gov/pubmed/26886104 http://dx.doi.org/10.1371/journal.pone.0149278 |
_version_ | 1782416463801352192 |
---|---|
author | Yamamoto, Tatsuya Tateno, Fuyuki Sakakibara, Ryuji Furukawa, Shogo Asahina, Masato Uchiyama, Tomoyuki Hirano, Shigeki Yamanaka, Yoshitaka Fuse, Miki Koga, Yasuko Yanagisawa, Mitsuru Kuwabara, Satoshi |
author_facet | Yamamoto, Tatsuya Tateno, Fuyuki Sakakibara, Ryuji Furukawa, Shogo Asahina, Masato Uchiyama, Tomoyuki Hirano, Shigeki Yamanaka, Yoshitaka Fuse, Miki Koga, Yasuko Yanagisawa, Mitsuru Kuwabara, Satoshi |
author_sort | Yamamoto, Tatsuya |
collection | PubMed |
description | BACKGROUND: Autonomic urinary dysfunction affects patients with progressive supranuclear palsy (PSP); however, the severity and prevalence of urinary dysfunctions in these patients compared with those observed in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA) are unknown. OBJECTIVE: We compared urinary dysfunction characteristics in patients with PSP, PD, and MSA. PATIENTS AND METHODS: Forty-seven patients who satisfied the probable or possible criteria of the National Institute for Neurological Diseases and Stroke and Society for PSP were assessed using the urinary symptoms questionnaire and the urodynamic study at Chiba and Toho Universities (n = 26 and 21, respectively). The results were compared with those of patients with PD and MSA (n = 218 and 193, respectively). RESULTS: The mean disease duration of PSP and the mean age were 2.97 ± 0.26 and 71.4 ± 0.88 years, respectively. The mini-mental state examination and frontal assessment battery scores were 22.6 ± 0.70 and 10.7 ± 0.49, respectively. Urinary storage and voiding symptoms were observed in 57% and 56% of patients with PSP, respectively. Detrusor overactivity in the urodynamic study was detected in 81% of patients with PSP, which was slightly more than that found in patients with PD (69%) and MSA (67%); however, this was not statistically significant. Postvoid residual volume in patients with PSP was significantly more than that in patients with PD (P < 0.01), but was equivalent to that in patients with MSA. CONCLUSIONS: The present study demonstrated that patients with PSP experienced various urinary dysfunctions. Urinary storage dysfunction in patients with PSP was not different from that in patients with PD or MSA, whereas urinary voiding dysfunction in patients with PSP was milder than that in patients with MSA and more severe than that in patients with PD. These features should be taken into account for the differentiation of PSP from PD and MSA. |
format | Online Article Text |
id | pubmed-4757534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47575342016-02-26 Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders Yamamoto, Tatsuya Tateno, Fuyuki Sakakibara, Ryuji Furukawa, Shogo Asahina, Masato Uchiyama, Tomoyuki Hirano, Shigeki Yamanaka, Yoshitaka Fuse, Miki Koga, Yasuko Yanagisawa, Mitsuru Kuwabara, Satoshi PLoS One Research Article BACKGROUND: Autonomic urinary dysfunction affects patients with progressive supranuclear palsy (PSP); however, the severity and prevalence of urinary dysfunctions in these patients compared with those observed in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA) are unknown. OBJECTIVE: We compared urinary dysfunction characteristics in patients with PSP, PD, and MSA. PATIENTS AND METHODS: Forty-seven patients who satisfied the probable or possible criteria of the National Institute for Neurological Diseases and Stroke and Society for PSP were assessed using the urinary symptoms questionnaire and the urodynamic study at Chiba and Toho Universities (n = 26 and 21, respectively). The results were compared with those of patients with PD and MSA (n = 218 and 193, respectively). RESULTS: The mean disease duration of PSP and the mean age were 2.97 ± 0.26 and 71.4 ± 0.88 years, respectively. The mini-mental state examination and frontal assessment battery scores were 22.6 ± 0.70 and 10.7 ± 0.49, respectively. Urinary storage and voiding symptoms were observed in 57% and 56% of patients with PSP, respectively. Detrusor overactivity in the urodynamic study was detected in 81% of patients with PSP, which was slightly more than that found in patients with PD (69%) and MSA (67%); however, this was not statistically significant. Postvoid residual volume in patients with PSP was significantly more than that in patients with PD (P < 0.01), but was equivalent to that in patients with MSA. CONCLUSIONS: The present study demonstrated that patients with PSP experienced various urinary dysfunctions. Urinary storage dysfunction in patients with PSP was not different from that in patients with PD or MSA, whereas urinary voiding dysfunction in patients with PSP was milder than that in patients with MSA and more severe than that in patients with PD. These features should be taken into account for the differentiation of PSP from PD and MSA. Public Library of Science 2016-02-17 /pmc/articles/PMC4757534/ /pubmed/26886104 http://dx.doi.org/10.1371/journal.pone.0149278 Text en © 2016 Yamamoto et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yamamoto, Tatsuya Tateno, Fuyuki Sakakibara, Ryuji Furukawa, Shogo Asahina, Masato Uchiyama, Tomoyuki Hirano, Shigeki Yamanaka, Yoshitaka Fuse, Miki Koga, Yasuko Yanagisawa, Mitsuru Kuwabara, Satoshi Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders |
title | Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders |
title_full | Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders |
title_fullStr | Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders |
title_full_unstemmed | Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders |
title_short | Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders |
title_sort | urinary dysfunction in progressive supranuclear palsy compared with other parkinsonian disorders |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757534/ https://www.ncbi.nlm.nih.gov/pubmed/26886104 http://dx.doi.org/10.1371/journal.pone.0149278 |
work_keys_str_mv | AT yamamototatsuya urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT tatenofuyuki urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT sakakibararyuji urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT furukawashogo urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT asahinamasato urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT uchiyamatomoyuki urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT hiranoshigeki urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT yamanakayoshitaka urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT fusemiki urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT kogayasuko urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT yanagisawamitsuru urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders AT kuwabarasatoshi urinarydysfunctioninprogressivesupranuclearpalsycomparedwithotherparkinsoniandisorders |